About Median
Median is a company based in Valbonne (France) founded in 2002 by Fredrik Brag. Median has raised $5.28 million across 4 funding rounds from investors including Idinvest Partners, Abingworth and NEA. Median offers products and services including eyonis, iCRO, and Imaging Lab. Median operates in a competitive market with competitors including Change Healthcare, AIdoc, HeartFlow, Cleerly and eCential Robotics, among others.
- Headquarter Valbonne, France
- Founders Fredrik Brag
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Median Technologies
-
Annual Revenue
$23.84 M (USD)3.25as on Dec 31, 2024
-
Net Profit
-$26.22 M (USD)-9.83as on Dec 31, 2024
-
EBITDA
-$21.28 M (USD)5.97as on Dec 31, 2024
-
Total Equity Funding
$5.28 M (USD)
in 4 rounds
-
Latest Funding Round
$33.15 M (USD), Post-IPO
Mar 26, 2021
-
Investors
Idinvest Partners
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Median
Median is a publicly listed company on the EURONEXT with ticker symbol ALMDT in France, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Median
Median offers a comprehensive portfolio of products and services, including eyonis, iCRO, and Imaging Lab.
AI tool for early detection of lung and liver cancer through image analysis.
Provides oncology trial imaging to accelerate cancer treatment development.
Generates AI-powered data for biopharma drug efficacy and patient selection.
People of Median
Unlock access to complete
Unlock access to complete
Funding Insights of Median
Median has successfully raised a total of $5.28M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $33.15 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Median
Median has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Idinvest Partners, Abingworth and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital firm investing in US
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Venture capital firm
|
Locked | Locked | Locked |
Investor details for Median
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Median
Investment portfolio details for Median
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Median
Detailed financials for Median
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Median Comparisons
Peer comparison for Median
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Median
Median operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Change Healthcare, AIdoc, HeartFlow, Cleerly and eCential Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based solutions are delivered for healthcare payers, providers, and patients.
|
|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Cardiovascular diagnostics are provided using CT scans and analytics.
|
|
| Locked | Locked | Locked |
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
Detailed competitors of Median
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Median
Complete news archive for Median
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Median
Median was founded in 2002 and raised its 1st funding round 2 years after it was founded.
Median is headquartered in Valbonne, France. It is registered at Valbonne, Provence-alpes-cote D'azur, France.
Fredrik Brag is the current CEO of Median. They have also founded this company.
Median is a funded company, having raised a total of $5.28M across 4 funding rounds to date.
Annual revenue of Median is $23.84M as on Dec 31, 2024.
Median was founded in 2002 in Valbonne, France, by Fredrik Brag. Medical imaging software and services are offered for clinical trials in the healthcare sector. Operations focus on SaaS-based Lesion Management Solutions (LMS), which detect, evaluate, and track lesions in CT scans through automatic and semi-automatic processes. Drug development and patient care markets are served. Cancer cells are identified via computer-aided detection technology.
Median's top competitors include Change Healthcare, AIdoc and eCential Robotics.
Median offers eyonis, iCRO, and Imaging Lab.
Yes, Median is publicly traded on EURONEXT under the ticker symbol ALMDT.
Median has 6 investors. Key investors include Idinvest Partners, Abingworth, NEA, Omega Funds, and DFJ.
The ticker symbol of Median is ALMDT on EURONEXT.